View in EDS HTML Full Text PDF Full Text

Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.

Saved in:
Bibliographic Details
Title: Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
Authors: Kashani-Sabet M; Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco., Leachman SA; Departments of Dermatology and Family Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland., Stein JA; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York., Arbiser JL; Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute, Atlanta Veterans Administration Health Center, Atlanta, Georgia., Berry EG; Departments of Dermatology and Family Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland., Celebi JT; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York., Curiel-Lewandrowski C; UA Cancer Center Skin Cancer Institute, Division of Dermatology, College of Medicine, University of Arizona, Tucson., Ferris LK; Departments of Dermatology and Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania., Grant-Kels JM; Department of Dermatology, University of Connecticut School of Medicine, Farmington.; Department of Dermatology, University of Florida College of Medicine, Gainesville., Grossman D; Huntsman Cancer Institute, University of Utah, Salt Lake City., Kulkarni RP; Departments of Dermatology and Family Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland., Marchetti MA; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston., Polsky D; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York., Seiverling EV; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts., Swetter SM; Department of Dermatology/Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Palo Alto, California.; Dermatology Service, VA Palo Alto Health Care System, Palo Alto, California., Tsao H; Department of Dermatology, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts., Verdieck-Devlaeminck A; Departments of Dermatology and Family Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland., Wei ML; Dermatology Department, University of California, San Francisco.; Dermatology Service, San Francisco VA Health Care System, San Francisco, California., Bar A; Departments of Dermatology and Family Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland., Bartlett EK; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Bolognia JL; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut., Bowles TL; Intermountain Medical Center, Murray, Utah., Cha KB; Department of Dermatology, Michigan Medicine, Ann Arbor., Chu EY; Department of Dermatology, University of Pennsylvania, Philadelphia., Hartman RI; Department of Dermatology, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts., Hawryluk EB; Department of Dermatology, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts., Jampel RM; Department of Dermatology, University of Maryland, Baltimore, Maryland., Karapetyan L; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Kheterpal M; Department of Dermatology, Duke University, Durham, North Carolina., Lawson DH; Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute, Atlanta Veterans Administration Health Center, Atlanta, Georgia., Leming PD; Cincinnati Cancer Advisors, Cincinnati, Ohio., Liebman TN; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York., Ming ME; Department of Dermatology, University of Pennsylvania, Philadelphia., Sahni D; Boston Medical Center, Boston, Massachusetts., Savory SA; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas., Shaikh SS; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Sober AJ; Department of Dermatology, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts., Sondak VK; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida., Spaccarelli N; Ohio State University Wexner Medical Center, Columbus., Usatine RP; University of Texas Health, San Antonio., Venna S; Inova Schar Cancer Institute, Inova Fairfax Hospital, University of Virginia School of Medicine, Charlottesville., Kirkwood JM; Departments of Dermatology and Medicine, University of Pittsburgh, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
Source: JAMA dermatology [JAMA Dermatol] 2023 May 01; Vol. 159 (5), pp. 545-553.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Consensus Statement
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2168-6084
DOI:10.1001/jamadermatol.2023.0127